argenx SE | ARGX - Operating Profit

Stock Price
618.20
Daily Change
1.40 0.23%
Monthly
-13.47%
Yearly
9.42%
Q1 Forecast
598.33

argenx SE reported $371.14M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
AstraZeneca USD 2.97B 4.48B Dec/2025
Galapagos EUR 780.56M 822.23M Dec/2025
Genmab DKK 360M 172M Jun/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
GRIFOLS EUR 275.38M 76.74M Dec/2025
Hikma Pharmaceutical USD 348M 161M Dec/2025
Qiagen NV USD 121.88M 15.41M Dec/2025
UCB EUR 1B 678M Dec/2024